Skip to content
DraconiticResearch
Search Sources API
194,164 studies31 sourcesUpdated 10 min ago
Peer-reviewedLicence not statedCytometry. Part B, Clinical cytometry

The fraction of CD117/c-KIT-expressing erythroid precursors predicts ESA response in low-risk myelodysplastic syndromes.

  • Raimbault A
  • Itzykson R
  • Willems L
  • Rousseau A
  • Chapuis N
  • Mathis S
  • Clauser S
  • Radford-Weiss I
  • Bouscary D
  • Fontenay M
  • Kosmider O
  • Valérie Bardet
Open at sourcePDFDOICite

Related

  1. Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
    Valérie Bardet, Wagner-Ballon O, Guy J +12
    HaematologicaPeer-reviewedLicence not statedFull text43 citedGeneral biologyGeneral medicineHAL
  2. Low-dose deferasirox for lower-risk myelodysplastic syndromes after erythropoiesis-stimulating agents (ESA) failure: results of the phase II LODEFI study
    Meunier Mathieu, Sylvain Thépot, Stanislas Nimubona +22
    HaematologicaPeer-reviewedCC BY-NCFull textGeneral biologyHAL
  3. The Predictive Value of Serum Erythropoietin Levels Measured at Diagnosis in Patients With Myelodysplastic Syndromes
    Dominic Culligan, Adele Taylor, Alexandra Smith +17
    eJHaemPeer-reviewedCC BYGeneral biologyHAL
  4. APG101 efficiently rescues erythropoiesis in lower risk myelodysplastic syndromes with severe impairment of hematopoiesis.
    Raimbault A, Pierre-Eugene C, Rouquette A +10
    OncotargetPeer-reviewedCC BY11 citedGeneral biologyGeneral medicineHAL
  5. Perturbation of the replication stress-ATR axis accelerates human erythroid differentiation but blocks terminal maturation
    J. Jauregui-Lozano, A. Kremer, K. D. Prummel +1
    bioRxivPreprintCC BY-NCFull textCell biologybioRxiv

Cite

BibTeXRIS
BibTeX
@article{raimbault2026fraction,
  title = {{The fraction of CD117/c-KIT-expressing erythroid precursors predicts ESA response in low-risk myelodysplastic syndromes.}},
  author = {Raimbault A and Itzykson R and Willems L and Rousseau A and Chapuis N and Mathis S and Clauser S and Radford-Weiss I and Bouscary D and Fontenay M and Kosmider O and Valérie Bardet},
  journal = {Cytometry. Part B, Clinical cytometry},
  year = {2026},
  month = oct,
  doi = {10.1002/cyto.b.21781},
  url = {https://hal.science/hal-05785528v1},
}
RIS
TY  - JOUR
TI  - The fraction of CD117/c-KIT-expressing erythroid precursors predicts ESA response in low-risk myelodysplastic syndromes.
AU  - Raimbault A
AU  - Itzykson R
AU  - Willems L
AU  - Rousseau A
AU  - Chapuis N
AU  - Mathis S
AU  - Clauser S
AU  - Radford-Weiss I
AU  - Bouscary D
AU  - Fontenay M
AU  - Kosmider O
AU  - Valérie Bardet
PY  - 2026
DA  - 2026/10/08
JO  - Cytometry. Part B, Clinical cytometry
DO  - 10.1002/cyto.b.21781
UR  - https://hal.science/hal-05785528v1
ER  -